fludarabine and Bright Disease

fludarabine has been researched along with Bright Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lipton, JH; Pierratos, A; Tisler, A1
Karadogan, I; Timuragaoglu, A; Undar, L1

Other Studies

2 other study(ies) available for fludarabine and Bright Disease

ArticleYear
Crescentic glomerulonephritis associated with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:11

    Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Antineoplastic Agents; Female; Glomerulonephritis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Vidarabine

1996
Irreversible renal failure in a patient with chronic lymphocytic leukemia treated with fludarabine.
    Annals of hematology, 1999, Volume: 78, Issue:2

    Topics: Acute Kidney Injury; Antimetabolites, Antineoplastic; Autoantibodies; Erythrocytes; Fatal Outcome; Glomerulonephritis; Humans; Immune Complex Diseases; Kidney Failure, Chronic; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Renal Dialysis; Salvage Therapy; Vidarabine

1999